Essential medicines and health products

Measuring transparency to improve good governance:

in the public pharmaceutical sector in Malawi

Measuring transparency to improve good governance in the public pharmaceutical sector, working document

Publication details

Number of pages: 66
Publication date: March 2009
Languages: English
WHO reference number: WHO/PSM/PAR/2008.8

The Good Governance for Medicines (GGM) assessment, aimed at measuring the extent of vulnerability to corruption in Malawi, is the first of its kind, both in the country and in Africa. The study was instituted to measure the level of transparency in the countryʹs pharmaceutical sector. Measuring corruption in this sector is a very complex process. In recognizing this, WHO initiated a GGM programme and developed tools to help countries carry out assessments to measure the levels of transparency and of vulnerability to corruption and to develop and implement national programmes...